Categories: 3DAnalyticsDiagnosticsEngineeringLifeMarketMedtechPlatformRoboticsTechnology
IMAI Medtech is on a mission to redefine the landscape of oncology diagnostics through its pioneering 3D histology technology. By focusing on the early and accurate diagnosis of cancer, IMAI aims to enhance therapeutic outcomes and significantly improve patient care.
Investors 1
Mentions in press and media 7
| Date | Title | Description |
| 08.04.2025 | University Hospital Zurich's Health Innovation Hub expands portfolio |
The Health Innovation Hub (HIH) is the startup support arm of the Innovation & Startup Center (ISC) of the USZ, which was founded by the USZ in 2018. The aim of the ISC is to promote entrepreneurship and innovation in healthcare at and... |
| 31.03.2025 | BioEntrepreneurship: Catalyzing innovation from Lab to market |
Swiss universities are innovation hubs, where novel ideas are born with the potential to address critical global challenges. Yet, without the right support, many of these promising concepts remain confined to the lab. The Institute of Rege... |
| 07.02.2025 | The Rise of Innovation: Spotlight on Swiss Startups in 2025 | In the heart of Switzerland, innovation is blossoming. The ZKB Pionierpreis Technopark 2025 has set the stage for a remarkable showcase of talent. With a record 54 applications, the competition is fierce. This year, a surge of 25% in submis... |
| 06.02.2025 | ZKB Pionierpreis Technopark 2025: Die Nominierten |
Der ZKB Pionierpreis Technopark hat in diesem Jahr mit 54 Bewerbungen erhalten und damit einen neuen Rekord aufgestellt: Gegenüber dem Vorjahr sind es 25 Prozent mehr Interessierte, die ihre Unterlagen eingereicht haben. Dies unterstreiche... |
| 08.07.2024 | New portfolio companies for S2S Ventures |
Designed for student entrepreneurs, S2S Ventures is an independent Students-2-Students venture capital fund offering CHF 25,000 in start-ups founded at Swiss institutions of higher education and provide them with personalized feedback and ... |
| 23.02.2024 | Progressing towards market entry with InnoBooster |
The InnoBooster program is an initiative of the Gebert Rüf Stiftung that provides university-based high-potential projects with a grant of CHF 150’000 to support the development of their solution. The new selection this year includes four ... |
| - | IMAI MedTech | “IMAI Medtech is on a mission to redefine the landscape of oncology diagnostics through its pioneering 3D histology technology. By focusing on the early and accurate diagnosis of cancer, IMAI aims to enhance therapeutic outcomes and signifi... |
Reviews 0
